Angela M. Cacace - Jun 17, 2024 Form 3 Insider Report for ARVINAS, INC. (ARVN)

Role: Chief Scientific Officer
Signature: /s/ Jared Freedberg, as attorney-in-fact for Angela M. Cacace
Stock symbol: ARVN
Transactions as of: Jun 17, 2024
Transactions value $: $0
Form type: 3
Date filed: 6/18/2024, 05:51 PM

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ARVN	Common Stock						8.44K	Jun 17, 2024	Direct	F1
holding	ARVN	Common Stock						15.8K	Jun 17, 2024	Direct	F2
holding	ARVN	Common Stock						11.6K	Jun 17, 2024	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ARVN	Stock Option (right to buy)							Jun 17, 2024	Common Stock	23.4K	$47.00	Direct	F4
holding	ARVN	Stock Option (right to buy)							Jun 17, 2024	Common Stock	38.4K	$34.37	Direct	F5
holding	ARVN	Stock Option (right to buy)							Jun 17, 2024	Common Stock	52.4K	$64.19	Direct	F6
holding	ARVN	Stock Option (right to buy)							Jun 17, 2024	Common Stock	37K	$78.30	Direct	F7
holding	ARVN	Stock Option (right to buy)							Jun 17, 2024	Common Stock	26.7K	$47.38	Direct	F8
holding	ARVN	Stock Option (right to buy)							Jun 17, 2024	Common Stock	20.5K	$19.36	Direct	F9
holding	ARVN	Stock Option (right to buy)							Jun 17, 2024	Common Stock	33.7K	$16.00	Direct	F10

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 919 shares of common stock of the issuer previously purchased by the reporting person under the issuer's 2018 Employee Stock Purchase Plan.
F2	The restricted stock units (each, an "RSU") were granted by the issuer on February 23, 2024, pursuant to its 2018 Stock Incentive Plan (the "Plan") and each RSU represents a contingent right to receive one share of the issuer's common stock upon settlement for no consideration. The RSUs vest over two years: 1/2 of the shares underlying the award shall vest on February 23, 2025, with the remainder of the shares vesting on February 23, 2026.
F3	The RSUs were granted by the Issuer on February 22, 2023, pursuant to the Plan and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs vest over four years: 1/4 of the shares underlying the award vested on February 22, 2024, with the remainder of the shares vesting in equal annual installments thereafter through February 23, 2027. The RSU amount reflects that 1,190 shares were sold to pay for taxes following the February 22, 2024 vesting.
F4	The option was granted by the Issuer on February 23, 2024, pursuant to the Plan. The shares underlying the option vest over two years: 1/2 of the shares underlying the award shall vest on February 23, 2025, with the remainder of the shares vesting on February 23, 2026.
F5	The option was granted by the Issuer on February 22, 2023, pursuant to the Plan. The shares underlying the option vest over four years: 1/4 of the shares underlying the award vested on February 22, 2024, with the remainder of the shares vesting in equal monthly installments following February 22, 2024 through February 23, 2027.
F6	The option was granted by the Issuer on February 23, 2022, pursuant to the Plan. The shares underlying the option vest over four years: 1/4 of the shares underlying the award vested on February 23, 2023, with the remainder of the shares vesting in equal monthly installments following February 23, 2023 through February 23, 2026.
F7	The option was granted by the Issuer on February 26, 2021, pursuant to the Plan. The shares underlying the option vest over four years: 1/4 of the shares underlying the award vested on February 26, 2022, with the remainder of the shares vesting in equal monthly installments following February 23, 2022 through February 23, 2025.
F8	The option was granted by the Issuer on February 27, 2020, pursuant to the Plan. The shares underlying the option vested over four years: 1/4 of the shares underlying the award vested on February 27, 2021 and the remainder of the shares vested in equal monthly installments following February 27, 2021 through February 27, 2024.
F9	The option was granted by the Issuer on March 1, 2019, pursuant to the Plan. The shares underlying the option vested over four years: 1/4 of the shares underlying the award vested on March 1, 2020 and the remainder of the shares vested in equal monthly installments following March 1, 2020 through March 1, 2023.
F10	The option was granted by the Issuer on September 26, 2018, pursuant to the Plan. The shares underlying the option vested over four years: 1/4 of the shares underlying the award vested on May 14, 2019 and the remainder of the shares vested in equal monthly installments following May 14, 2019 through May 14, 2022.